- ￥2890
- LSM Bio
- 0.156-10ng/ml
- 0.078ng/ml
- 国产
- ELI-25352h
- 2026年03月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
20
- 供应商：
LSMBIO
- 检测范围：
0.156-10ng/ml
- 检测方法：
夹心法/竞争法
- 应用：
夹心法/竞争法ELISA体外定量检测人血清、血浆或其它相关生物液体中蛋白浓度
- 适应物种：
人
- 标记物：
Breast cancer metastasis-suppressor 1,BRMS1
- 样本：
人血清、血浆或其它相关生物液体中天然和重组蛋白
- 灵敏度：
0.078ng/ml
- 规格：
96T
Human Breast cancer metastasis- suppressor 1, BRMS1 ELISA KIT
Product Name:Human Breast cancer metastasis- suppressor 1, BRMS1 ELISA KIT
Packing:96T
Catalog No.:ELI-25352h
Gene Name:BRMS1
Detect Range:0.312-20 ng/mL
Sensitivity:0.039ng/mL
Target Protein Name:Breast cancer metastasis-suppressor 1(BRMS1
Alternative Name:BRMS1,Breast cancer metastasis-suppressor 1(BRMS1
Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA Kit
Product Description:Human Breast cancer metastasis- suppressor 1, BRMS1 ELISA KIT allows for the in vitro quantitative determination of Breast cancer metastasis-suppressor 1(BRMS1 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:
The microtiter plate provided in Human Breast cancer metastasis- suppressor 1, BRMS1 ELISA KIT has been pre-coated with an Breast cancer metastasis-suppressor 1(BRMS1 antibody specific to Breast cancer metastasis-suppressor 1(BRMS1 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Breast cancer metastasis-suppressor 1(BRMS1 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Breast cancer metastasis-suppressor 1(BRMS1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of Breast cancer metastasis-suppressor 1(BRMS1 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验In Vivo Xenograft Models of Breast Cancer Metastasis
immunodeficient mice. In severe combined immunodeficient mice, metastasizing human breast cancer cell lines were identified by their ability to bind the lectin Helix pomatia agglutinin, which was identified as a marker of metastasis in clinical studies. This model
to find a generalizable signature for prediction of breast cancer relapse by superimposition of a large-scale protein–protein interaction data (human interactome) over several gene expression datasets. ITI extracts regions in the interactome whose expression
The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
技术资料暂无技术资料 索取技术资料
